- Home
- ADI vs GSK Comparison
ADI vs GSK Comparison
Compare ADI & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADI
- GSK
- Stock Information
- Founded
- ADI 1965
- GSK 1715
- Country
- ADI United States
- GSK United Kingdom
- Employees
- ADI N/A
- GSK N/A
- Industry
- ADI Semiconductors
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- ADI Technology
- GSK Health Care
- Exchange
- ADI Nasdaq
- GSK Nasdaq
- Market Cap
- ADI 88.5B
- GSK 78.9B
- IPO Year
- ADI 1972
- GSK N/A
- Fundamental
- Price
- ADI $213.98
- GSK $41.01
- Analyst Decision
- ADI Buy
- GSK Hold
- Analyst Count
- ADI 22
- GSK 4
- Target Price
- ADI $241.90
- GSK $47.00
- AVG Volume (30 Days)
- ADI 4.5M
- GSK 5.1M
- Earning Date
- ADI 05-22-2025
- GSK 04-30-2025
- Dividend Yield
- ADI 1.85%
- GSK 3.91%
- EPS Growth
- ADI N/A
- GSK N/A
- EPS
- ADI 3.68
- GSK 0.98
- Revenue
- ADI $9,818,656,000.00
- GSK $40,735,668,430.00
- Revenue This Year
- ADI $10.75
- GSK $6.70
- Revenue Next Year
- ADI $13.06
- GSK $5.42
- P/E Ratio
- ADI $58.15
- GSK $20.21
- Revenue Growth
- ADI N/A
- GSK 2.57
- 52 Week Low
- ADI $158.65
- GSK $31.72
- 52 Week High
- ADI $247.10
- GSK $45.01
- Technical
- Relative Strength Index (RSI)
- ADI 54.09
- GSK 66.32
- Support Level
- ADI $206.00
- GSK $39.05
- Resistance Level
- ADI $218.50
- GSK $39.65
- Average True Range (ATR)
- ADI 5.18
- GSK 0.60
- MACD
- ADI -1.25
- GSK 0.27
- Stochastic Oscillator
- ADI 35.00
- GSK 96.94
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.